Bio-IT World November 17, 2022
High-resolution mass spectrometry methods are in principle “good enough” to put into clinics everywhere to measure low-abundance environmental chemicals and start cataloguing individual exposures, according to Dean Jones, Ph.D., professor of medicine and biochemistry at Emory University and director of its Clinical Biomarkers Laboratory. Jones was speaking at the Mayo Clinic’s recent Individualizing Medicine Conference focused on the “exposome”—the measure of all the exposures of an individual in a lifetime and how those exposures relate to health—and his presentation examined clinical exposomics as a foundation for precision medicine.
As Jones sees it, clinical exposomics can be built on what is being learned in environmental epidemiology, or what he calls exposome epidemiology. New analytical capabilities can characterize...
Today's Sponsors
Today's Sponsor